SENZA SenzaGen AB (publ)

0.4419USD4.490 SEK · STO-0.44%Mkt Cap: 14.37M USDP/E: —

SenzaGen AB (publ) provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. I…

Key Statistics

Company
Market Cap14.37M USD
Enterprise Value12.70M USD
Revenue (TTM)6.11M USD
Gross Profit3.70M USD
Net Income (TTM)-1.14M USD
Revenue/Share0.19 USD
Last Price0.4419 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees34
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISINSE0010219626
Valuation
P/E (Trailing)—
P/E (Forward)-44.90
PEG—
EV/EBITDA20.20
EV/Revenue2.08
P/S2.35
P/B1.57
EPS (TTM)-0.02 USD
EPS (Forward)-0.0098 USD
52W Range
0.414411% of range0.6595
52W High0.6595 USD
52W Low0.4144 USD
Profitability
Gross Margin64.80%
Oper. Margin-10.42%
EBITDA Margin10.29%
Profit Margin-19.99%
ROE-14.91%
ROA-9.98%
ROIC-15.45%
ROCE-11.85%
Growth
Revenue Growth6.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-671.58K USD
CapEx (TTM)540.08K USD
FCF Margin-8.83%
FCF Yield-3.76%
Net Debt-1.67M USD
Net Debt/EBITDA-2.66
Net Debt/FCF—
Balance Sheet
Debt/Equity0.24
Current Ratio3.68
Quick Ratio3.11
Book Value/Sh0.28 USD
Cash/Share0.10 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.32.51M
Float24.42M
Insiders23.61%
Institutions12.16%
Technical
SMA 500.4612 (-4.2%)
SMA 2000.5111 (-13.5%)
Beta0.47
S&P 52W Chg12.00%
Avg Vol (30d)34.19K
Avg Vol (10d)39.72K
Technical Indicators
RSI (14)43.1
MACD-0.0380
MACD Signal-0.0026
MACD Hist.-0.0354
BB Upper0.5049 USD
BB Middle0.4599 USD
BB Lower0.4148 USD
BB Width19.59%
ATR (14)0.0259 USD
Vol Ratio (20d)0.95x

About SenzaGen (STO: SENZA)

›

SenzaGen (STO: SENZA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 34 employees.

The shares were at 4.490 SEK on 19 November 2026, down 27.8% over 52 weeks. Its 52-week range is 4.210 SEK to 6.700 SEK: the price is 33.0% below the high and 6.7% above the low.

Its market capitalisation is 145.96M SEK.

SenzaGen reports return on equity of -14.9%, an operating margin of -10.4% and revenue up 6.8% year over year.

It holds more cash than debt, a net cash position of 16.97M SEK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.